"Neuromod secures €10m to expand tinnitus treatment device’s availability" was originally created and published by Medical Device Network, a GlobalData owned brand. The inform ...

Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...

It affects about one in eight people. The group’s treatment device, Lenire, has been shown to soothe and relieve tinnitus in large-scale clinical trials. It works by delivering mild electrical ...

The start-up intends to use the latest infusion to further fuel the European commercialisation of its tinnitus device Lenire, as well as to scale up its manufacturing and progress its US Food and ...

35 USVA facilities have been trained to provide treatment with Lenire with more scheduled for training in 2025. Positive results for tinnitus patients treated with Lenire in real-world settings at ...

An innovative treatment offers hope to the millions of people who hear sounds that others don’t. Here’s how it works. Warning: This graphic requires JavaScript ...

Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.

Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, its tinnitus treatment device. Current investors Panakès Partners ...

Following FDA approval in March 2023, more than 100 clinics throughout the USA now treat tinnitus patients with Lenire. Availability of Lenire has also expanded in Europe with clinics in 14 ...